[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":12451000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":2778000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2222000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":44206000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":14000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":9000.0,"FinanceLeaseInterestExpense_1_Q2_USD":1000.0,"AccountsReceivableBilledForLongTermContractsOrPrograms_0_Q2_USD":14049000.0,"FinanceLeaseInterestExpense_2_Q2_USD":2000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":17000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":43000.0,"FinanceLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":10000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":19000.0,"FinanceLeaseLiability_0_Q2_USD":39000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1660000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":7820000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":2778000.0,"SellingAndMarketingExpense_1_Q2_USD":14290000.0,"SellingAndMarketingExpense_2_Q2_USD":32128000.0,"StockRepurchasedDuringPeriodValue_1_Q2_USD":17000.0,"StockRepurchasedDuringPeriodValue_2_Q2_USD":658000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":22000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":9101000.0,"AccruedSalariesCurrent_0_Q2_USD":6103000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":519000.0,"PrepaidInsurance_0_Q2_USD":1077000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":59883000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":85930000.0,"PaymentsToAcquireInvestments_2_Q2_USD":22965000.0,"ShortTermInvestments_0_Q2_USD":24009000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-6000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2222000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":10000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1784000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":4000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":76000.0,"OperatingLeaseCost_1_Q2_USD":491000.0,"OperatingLeaseLeaseIncomeLeasePayments_2_Q2_USD":915000.0,"OperatingLeaseLiability_0_Q2_USD":3165000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1536000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1629000.0,"OperatingLeasePayments_2_Q2_USD":915000.0,"OperatingLeaseCost_2_Q2_USD":976000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3138000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":658000.0,"PrepaidAdvertising_0_Q2_USD":417000.0,"RepaymentsOfDebt_2_Q2_USD":7820000.0,"RestrictedCash_0_Q2_USD":10610000.0,"ShortTermLeaseCost_2_Q2_USD":10000.0,"ShortTermLeaseCost_1_Q2_USD":10000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.06,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":210000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":931000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3007000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":11000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":6000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0728,"InsuranceReceivableForMalpracticeCurrent_0_Q2_USD":21000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":2964000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":771000.0,"InventoryWriteDown_2_Q2_USD":1624000.0,"InvestmentIncomeNonoperating_1_Q2_USD":237000.0,"InvestmentIncomeNonoperating_2_Q2_USD":548000.0,"LeaseCost_1_Q2_USD":559000.0,"LeaseCost_2_Q2_USD":1060000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":41621000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":2601000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2539000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3525000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":8000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":35000000.0,"LongTermDebtCurrent_0_Q2_USD":1553000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":-115000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3010000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1699000.0,"InventoryNet_0_Q2_USD":12836000.0,"Liabilities_0_Q2_USD":50201000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":169961000.0,"LiabilitiesCurrent_0_Q2_USD":14018000.0,"GrossProfit_2_Q2_USD":35956000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":35768000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-15081000.0,"NetIncomeLoss_2_Q2_USD":-16297000.0,"NetIncomeLoss_1_Q2_USD":-8105000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":13183000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3405000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":24858000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":23519000.0,"GrossProfit_1_Q2_USD":16511000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11906000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6404000.0,"AccountsPayableCurrent_0_Q2_USD":3887000.0,"AccountsReceivableNetCurrent_0_Q2_USD":14049000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2459220.0,"Assets_0_Q2_USD":169961000.0,"AssetsCurrent_0_Q2_USD":140229000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":75320000.0,"CommonStockSharesIssued_0_Q2_shares":40020780.0,"CommonStockSharesOutstanding_0_Q2_shares":40020780.0,"CommonStockValue_0_Q2_USD":400000.0,"CostsAndExpenses_1_Q2_USD":24765000.0,"CostsAndExpenses_2_Q2_USD":52719000.0,"Depreciation_1_Q2_USD":311000.0,"Depreciation_2_Q2_USD":618000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.2,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.41,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-196158000.0,"Revenues_1_Q2_USD":22116000.0,"Revenues_2_Q2_USD":46377000.0,"StockholdersEquity_0_Q2_USD":119760000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":29240000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":1660000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-57000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-20000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":617000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":5605000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":10421000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":2563000.0,"LongTermDebt_0_Q2_USD":31960000.0,"NonoperatingIncomeExpense_1_Q2_USD":149000.0,"NonoperatingIncomeExpense_2_Q2_USD":466000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":350000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2461000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":315518000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":216000.0,"IncreaseDecreaseInInventories_2_Q2_USD":600000.0,"VariableLeaseCost_1_Q2_USD":51000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-4212000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":36000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":39823414.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":39760602.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"InterestPaidNet_2_Q2_USD":23000.0,"OperatingIncomeLoss_1_Q2_USD":-8254000.0,"OperatingIncomeLoss_2_Q2_USD":-16763000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4071000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":8685000.0,"ShareBasedCompensation_2_Q2_USD":2778000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.5952,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0038,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4382000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":419000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":72000.0,"VariableLeaseCost_2_Q2_USD":61000.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]